Kencur's Sedative Pharmacology and the Energy-Marketing Myth
Because kencur shares a genus with black ginger (Kaempferia parviflora) — a plant with real human trials behind sports-performance and energy marketing — kencur itself occasionally turns up in the same "energy" and "vitality" territory. A direct, systematic PubMed search for kencur combined with fatigue, exercise, endurance, or athletic performance returns zero results. What a search for kencur's actual central-nervous-system pharmacology returns is the opposite of an energizer: a real, twice-confirmed sedative effect, by two different research groups using two different routes of administration. This page reports both findings side by side, and explains what they mean for a marketing claim that, on kencur specifically, has no laboratory or traditional basis at all.
Table of Contents
- A Name That Gets Marketed as an Energizer
- What We Actually Searched For: Zero Athletic-Performance Trials
- The Real Pharmacology, Confirmed Orally: A Sedative, Not a Stimulant
- Confirmed by a Second Route: Inhalation and Aromatherapy
- Why the Main Kencur Page Already Warns About This
- A Different Kind of Relaxation: Vasodilation, Not Sedation
- Where the Real Athletic Evidence Lives: The Other Kaempferia
- What Kencur Is Actually Used For, by the People Who Use It Daily
- Benefit and Hazard, One Mechanism
- Practical Guidance
- Key Research Papers
- Connections
A Name That Gets Marketed as an Energizer
The main Kencur page already devotes a full section to the fact that kencur (Kaempferia galanga) is routinely confused with black ginger (Kaempferia parviflora) — same genus, different species, different rhizome color, different chemistry, and a completely different evidence base. Black ginger has real randomized, placebo-controlled human trials behind sports-performance and physical-fitness claims. That distinction is worth repeating here for a specific reason: it is precisely the kind of confusion that lets an energy or athletic-performance claim drift from one species onto the other in marketing copy, especially when a supplement label lists only the shared genus name, or leans on a shared trade term like "Thai ginseng." This page exists to check, directly, whether kencur has any pharmacology of its own that would support that drift — and to report plainly what was actually found instead.
What We Actually Searched For: Zero Athletic-Performance Trials
Rather than assume the absence of evidence, this page reports the actual search performed, so the negative finding is checkable rather than asserted. A PubMed search of title and abstract fields, phrase-locked to "Kaempferia galanga" to exclude black ginger, combined with any of the terms fatigue, exercise, ergogenic, athletic, endurance, or "physical performance," returns zero records. Not a small number, not a handful of weak or tangential hits — zero. Every one of the specific, validated citations in the digestive-health, anti-inflammatory, and antimicrobial pages elsewhere in this Benefits set exists somewhere in PubMed's index; this particular search string simply does not match anything, at any quality level, for this species.
Naming the validated methods that do exist for measuring exactly this kind of claim makes the absence more concrete than a bare "no evidence" statement: physical-performance research uses standardized, repeatable protocols — time-to-exhaustion treadmill or cycle-ergometer tests, grip-strength dynamometry, VO2 max testing, blood lactate curves, and validated fatigue questionnaires. All of these tools exist, are inexpensive relative to a drug trial, and have been applied to black ginger specifically, discussed below. None has been applied to kencur.
The Real Pharmacology, Confirmed Orally: A Sedative, Not a Stimulant
What the literature contains instead of energizing pharmacology is the opposite: genuine, specific evidence for central nervous system depression. Ali, Dash, and Nasrin (2015) tested oral extracts and fractions of kencur rhizome and leaf in Swiss albino mice, using three standard, validated sedative-activity assays: thiopental-induced sleeping time (how long a barbiturate-induced sleep lasts, extended by a genuine sedative), and the hole-cross and open-field tests (both measure spontaneous exploratory movement, reduced by sedation).
The results were substantial, not marginal. At 200 mg/kg, the chloroform fraction of the rhizome extended thiopental-induced sleep duration by 358.55% relative to control — more than the standard sedative drug comparator, diazepam (2 mg/kg), which extended sleep by 231.42% in the same experiment. In the hole-cross and open-field tests, the acetone leaf extract suppressed locomotor activity by up to 95.5–95.6%, again exceeding diazepam's 70.6–71.7% suppression in the same study. The researchers' own framing places this squarely in traditional context: kencur has long been used in Bangladesh, India, China, Japan, and across Indochina "to help restlessness, stress, anxiety, depression," and this was explicitly designed as one of the only studies to test that neuropharmacological reputation directly, rather than the pain or antimicrobial properties tested elsewhere.
A study extract outperforming diazepam on these specific rodent measures is a striking result and, as with the pain-pharmacology findings on the Pain and Inflammation page, should be read with the same caution about rodent-to-human translation: these are validated animal screening assays for sedative activity, genuinely useful for confirming a compound class is centrally active, but not equivalent to a clinical sedative or anxiolytic effect demonstrated in a person.
Confirmed by a Second Route: Inhalation and Aromatherapy
What makes kencur's sedative pharmacology more than a single-study finding is that a second, independent research group found the same effect through an entirely different route of administration. Huang, Yagura, and Chen (2008) tested kencur specifically by inhalation — the hexane extract and two of its major aromatic compounds (EPMC and ethyl cinnamate) delivered as vapor to mice, rather than swallowed. Inhaling the hexane extract at doses of just 1.5 and 10 mg produced significant reduction in locomotor activity. The two isolated aromatic compounds were active at strikingly small doses by this route — 0.0014 mg for EPMC and 0.0012 mg for ethyl cinnamate, roughly a thousand-fold smaller than the oral doses in the Ali 2015 study, which makes sense given how differently an inhaled aromatic compound reaches the brain compared to a swallowed extract processed by the digestive system and liver first.
A separate, earlier study lends further support from yet another angle. Fujiwara and Ito (2015) tested the sedative activity of eight aromatic oils traditionally used in Japanese scent sachets, including galangal oil (labeled in the paper as Kaempferia galanga), via inhalation in an open-field test. Galangal was one of five oils (alongside patchouli, sandalwood, spikenard, and borneol) that produced significant sedative effects on their own, and the combined mixture of all five was more strongly sedative than any single oil — a plausible synergy, though tested only as a whole-mixture effect, without isolating which pairs or ratios drive it.
The route distinction matters and is worth stating plainly rather than glossing over: an oral dose (Ali 2015, milligrams per kilogram) and an inhaled dose (Huang 2008, fractions of a milligram total) are different interventions delivering the active compounds to the body by entirely different paths, at doses that are not directly comparable. That two independent research groups, using two different delivery routes and different assays, both found sedative rather than stimulant activity is the real strength of this evidence — not that either single study proves a specific clinical effect.
Why the Main Kencur Page Already Warns About This
This is not a new finding contradicting the rest of the site: the main Kencur page already lists "Sedatives and CNS depressants" among its cautions, noting that animal studies report sedative and central depressant effects and that this is plausible as an interaction with benzodiazepines, sleep medication, opioids, or alcohol. This page is the detailed evidence behind that existing, brief caution.
It connects directly to a third data point covered in depth on the Pain and Inflammation page's safety section: Kanjanapothi and colleagues' 2004 toxicology study, whose initial Hippocratic screening test of the ethanolic rhizome extract in rats documented specific, textbook signs of CNS depression — decreased motor activity, decreased respiratory rate, loss of the screen-grip reflex, and analgesia (reduced pain response) — entirely independent of, and years before, either of the two dedicated sedative-activity studies above. Three separate research teams, using three different methodologies (a general toxicological screen, a dedicated oral sedative-activity study, and a dedicated inhalation sedative-activity study), converge on the same conclusion. That kind of convergence across independent methods is one of the more credible patterns this Benefits set has found for any claim about kencur, on either the benefit or the caution side of the ledger.
A Different Kind of Relaxation: Vasodilation, Not Sedation
One more finding deserves mention here specifically to keep it separate, not to add to the sedative case. Srivastava and colleagues (2021), covered in full on the Pain and Inflammation page, found that EPMC relaxes isolated rat mesenteric artery tissue through calcium-activated potassium channels in vascular smooth muscle — a real, separate pharmacological effect, but in blood vessel tissue, not the brain or central nervous system, and via a distinct ion-channel mechanism from the CNS-depressant activity described above. "Relaxation" of a blood vessel and "sedation" of an animal's behavior are two different phenomena in two different organ systems that happen to share a word in casual English; conflating them — for instance, by describing kencur generally as "relaxing" and letting a reader infer either meaning — would overstate what either individual study actually shows. Kencur's confirmed CNS pharmacology is specifically the oral and inhaled sedative-activity findings above.
Where the Real Athletic Evidence Lives: The Other Kaempferia
For direct contrast, and so the two species' evidence never gets casually merged in a reader's memory, the two real black-ginger human trials the main Kencur page already cites are worth restating precisely here. Promthep and colleagues (2015) ran a randomized, double-blind, placebo-controlled trial of Kaempferia parviflora extract on physical fitness in soccer players — a real trial, in real athletes, with a real placebo arm, on the species that is not kencur. Yoshino and colleagues (2019) ran a dedicated randomized, placebo-controlled safety trial of daily Kaempferia parviflora consumption. Whatever the size of the effects reported in either trial, the trials themselves exist, were conducted in the correct species, and used the correct human, placebo-controlled design that kencur's own literature entirely lacks. A reader interested in the genuinely tested athletic-performance and energy claim should look at the Black Ginger page, not at kencur.
What Kencur Is Actually Used For, by the People Who Use It Daily
One further piece of evidence is worth including here, not as pharmacology but as a real, systematic record of what kencur is actually reached for in the communities that use it daily. Ekasari and colleagues (2025) conducted a formal ethnobotanical survey — structured interviews, group discussions, and guided field visits with 111 informants — across three regions of East Java specifically documenting traditional herb use for cough and colds. Kaempferia galanga was the single most-cited plant for treating cough (27 use-reports, the highest use-value score of any species in the cough category), ahead of every other plant surveyed for that indication.
This is not a test of whether kencur actually relieves cough — no controlled trial of that claim exists either, and it is a different, absent piece of evidence from the sedative pharmacology this page is chiefly about. It is included here for a narrower and more relevant reason: it is a real, recent, methodologically documented snapshot of what a community that has used this plant for generations actually reaches for it to do, and the answer — cough and cold, a calming and restorative household remedy — sits far closer to the confirmed sedative pharmacology above than to any energy or athletic-performance claim. The traditional use pattern and the laboratory pharmacology point the same direction; the "energy" marketing angle is the outlier, unsupported by either.
Benefit and Hazard, One Mechanism
It is worth stating the underlying logic plainly, because it is the same CNS-depressant activity doing double duty as both a traditional-use explanation and a modern safety caution — benefit and hazard described from two different angles rather than two separate facts. The same property that plausibly explains centuries of traditional use for "restlessness, stress, anxiety" (in Ali and colleagues' own framing of the tradition they were testing) is exactly the property that makes combining concentrated kencur extract with alcohol, benzodiazepines, opioids, or other sedating medication a real, if untested in humans, concern. This is not a contradiction to resolve; it is one pharmacological fact with two consequences, and both consequences are true at once. It is also, incidentally, the most concrete evidence-based reason kencur does not belong anywhere near a pre-workout or energy product: a genuine CNS depressant is mechanistically the wrong direction for that use case, not merely an unproven one.
Practical Guidance
Kencur as a kitchen spice, in culinary amounts, carries no meaningful sedative burden and needs no special caution on this basis alone — the active doses in the animal studies above, especially the oral study, involve concentrated extracts, not a few grams of rhizome in a peanut sauce. A cup of traditional beras kencur jamu is a more concentrated exposure than a cooked dish and, given the real if animal-only sedative signal, is a reasonable thing to be modestly cautious about combining with alcohol or sedating medication, in the same spirit as the main page's existing caution. A concentrated kencur extract, capsule, or essential oil is where this evidence actually applies most directly: anyone taking benzodiazepines, sleep medication, opioids, or who drinks alcohol regularly should treat a CNS interaction as plausible, even though untested, and should not expect any energizing or athletic-performance benefit from kencur specifically — that claim, to the extent it exists in the marketplace, belongs to a different plant.
Key Research Papers
- Ali MS, Dash PR, Nasrin M. Study of sedative activity of different extracts of Kaempferia galanga in Swiss albino mice. BMC Complementary and Alternative Medicine, 2015;15:158. — PubMed
- Huang L, Yagura T, Chen S. Sedative activity of hexane extract of Kaempferia galanga L. and its active compounds, by inhalation. Journal of Ethnopharmacology, 2008;120(1):123–125. — PubMed
- Fujiwara Y, Ito M. Synergistic effect of fragrant herbs in Japanese scent sachets. Planta Medica, 2015;81(3):193–199. — PubMed
- Kanjanapothi D, Panthong A, Lertprasertsuke N, et al. Toxicity of crude rhizome extract of Kaempferia galanga L. (Proh Hom) — Hippocratic screening documented CNS depression signs. Journal of Ethnopharmacology, 2004;90(2–3):359–365. — PubMed
- Srivastava N, Mishra S, Iqbal H, Chanda D, Shanker K. Standardization of Kaempferia galanga L. rhizome and vasorelaxation effect of its key metabolite ethyl p-methoxycinnamate (a distinct, non-CNS mechanism). Journal of Ethnopharmacology, 2021;271:113911. — PubMed
- Wang SY, Zhao H, Xu HT, et al. Kaempferia galanga L.: progresses in phytochemistry, pharmacology, toxicology and ethnomedicinal uses. Frontiers in Pharmacology, 2021;12:675350. (Comprehensive review.) — PubMed
- Kumar A. Phytochemistry, pharmacological activities and uses of traditional medicinal plant Kaempferia galanga L. — an overview. Journal of Ethnopharmacology, 2020;253:112667. (Comprehensive review.) — PubMed
- Promthep K, Eungpinichpong W, Sripanidkulchai B, et al. Effect of Kaempferia parviflora extract on physical fitness of soccer players — a randomized, double-blind, placebo-controlled trial (black ginger, the other Kaempferia species, not kencur). Medical Science Monitor Basic Research, 2015;21:100–108. — PubMed
- Yoshino S, Awa R, Miyake Y, et al. Evaluation of the safety of daily consumption of Kaempferia parviflora extract — a randomized, double-blind, placebo-controlled trial (black ginger, again not kencur). Journal of Medicinal Food, 2019;22(11):1168–1174. — PubMed
- Ekasari W, Widyowati R, Kurnia ND, Jayanegara AQ, Sari AL, Sahu RK. Exploration of the use of traditional herbs to overcome cough and cold in three provinces of East Java province (K. galanga most-cited for cough). The Scientific World Journal, 2025;2025:1622754. — PubMed